Oklo Option Alert: Jan, 2026 $60 Calls Sweep (3) near the Ask: 310 vs 777 OI; Earnings 2/25 After Close [est] 

Oklo Option Alert: Jan, 2026 $60 Calls Sweep (3) near the Ask: 310 @ $19.8 vs 777 OI; Earnings 2/25 After Close [est] Ref=$53.18

Oklo (NYSE:OKLO) Stock

Oklo

Oklo Inc is developing advanced fission power plants to provide clean, reliable, and affordable energy at scale. It is pursuing two complementary tracks to address this demand: providing reliable, commercial-scale energy to customers; and selling used nuclear fuel recycling services to the U.S. market. The Company plans to commercialize its liquid metal fast reactor technology with the Aurora powerhouse product line. The first commercial Aurora powerhouse is designed to produce up to 15 megawatts of electricity (MWe) on both recycled nuclear fuel and fresh fuel.

ASTSpaceMobile.Screenshotvideo

Equities

Mid Cap

News

Movers

Tech

Trading Ideas

ASTS

IREN

MGNI

OKLO

TDOC

VNET

Top mid-cap stock performers last week: Kingsoft Cloud up 34.77%, Oklo Inc. up 33.36%, AST SpaceMobile up 30.98%, VNET Group up 29.12%, Teladoc Health up 27.46%, GDS Holdings up 25.68%, Magnite up 23.08%, SolarWinds up 23.05%, Lions Gate Entertainment up 22.68%, IREN Limited up 22.02%.

AST SpaceMobile, Teladoc Health And IREN Are Among Top 10 Mid Cap Gainers Last Week (Feb 3-Feb 7): Are The Others In Your Portfolio?

Brinker

Intraday Update

Markets

CSGS

FFIV

IBRX

LPRO

PACK

SBUX

SYNA

TMUS

Brinker International Posts Upbeat Results, Joins F5, T-Mobile US, Starbucks And Other Big Stocks Moving Higher On Wednesday

LTBR



The global demand for clean, reliable baseload energy is reaching unprecedented levels, driven by the voracious needs of data centers, cryptocurrency, the artificial intelligence (AI) revolution, and a worldwide

Oklo&#39;s Fuel Partnership Strengthens Bullish Case for Stock

Oklo Inc

Occidental Petroleum Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OXY#NYSE">OXY</a>) shares are moving higher on Wednesday as oil prices rise following a drone attack on a Russian pipeline, which could <a href="https://www.benzinga.com//node/43817326">weaken supply</a>.
The Details: The drone attack, which took place on Monday, targeted the Kropotkinskaya station located in Krasnodar, according to Reuters. The Kropotkinskaya station is the largest pumping station on the pipeline in Russia and is responsible for pumping about 1% of global crude oil supply.
The Caspian Pipeline Consortium oversees the pipeline and, as of Monday, has not identified those responsible for the attack. However, it confirmed that the Kropotkinskaya facility was shut down, and crude oil flow through the Tengiz-Novorossiysk pipeline system was being maintained at reduced rates, bypassing the pumping station.
Deputy chairman of Russia&#8217;s Security Council Dmitry Medvedev stated, &#8220;Ukrainian drones attacked a pumping station that provides oil transportation through the main oil pipeline of the Caspian Pipeline Consortium. A blow to an oil consortium could stop oil pumping, unbalance the market, increase oil price spikes and cause direct damage to American companies.&#8221;
Furthermore, Medvedev said that Ukraine's attack on a pipeline partially owned by U.S. companies was a blow against President Donald Trump, who has sought lower oil prices. He added that it remained to be seen how Trump would respond.
Occidental shares may be rising following the drone attack, as reduced supply could drive up prices, potentially boosting profits. The attack may also heighten concerns over geopolitical tensions, prompting investors to buy oil stocks as a hedge against future supply uncertainty.
What Else: Occidental reported earnings for the 2024 fiscal-year fourth-quarter after the market closed on Tuesday. The company reported adjusted earnings per share of 80 cents, beating analysts&#8217; estimate of 70 cents. In addition, it reported sales of $6.83 billion, missing analysts&#8217; estimate of $7.05 billion.
Additionally, Occidental announced it achieved its near-term debt repayment target of $4.5 billion in the fourth-quarter. In the 2025 first-quarter, it signed two agreements to divest upstream assets for a combined total of $1.2 billion.
Related Link: <a href="https://www.benzinga.com/25/02/43821108/garmin-posts-better-than-expected-results-joins-solaredge-technologies-compass-appian-and-other-big-stocks-moving-higher-on-wednesday">Garmin Posts Better-Than-Expected Results, Joins SolarEdge Technologies, Compass, Appian And Other Big Stocks Moving Higher On Wednesday</a>
OXY Price Action: At the time of writing, Occidental shares are trading 4.22% higher at $50.90, according to data from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Image: via Shutterstock

What's Going On With Occidental Petroleum Stock Wednesday?

President Donald Trump continues to plan and place tariffs on imported goods from several countries, due to what he calls an unfair trade balance <a href="https://www.benzinga.com/news/global/25/02/43442219/why-beer-tequila-avocados-cars-iphone-prices-could-rise-trumps-tariffs-on-canada-mexico-china-to-hurt-several-sectors">with other nations.</a>
A recent Benzinga poll shows what impact Trump's tariffs could have on the stock market.
What Happened: On Tuesday, Trump said he plans <a href="https://www.benzinga.com/25/02/43805852/trump-shakes-global-trade-with-25-auto-chip-and-pharma-tariffs-announcement-asian-stocks-pare-their-five-day-rally">to place tariffs </a>on several sectors, including automotive, semiconductors and pharmaceuticals.
Trump said automotive tariffs would come "in the neighborhood of 25%." A report said the tariffs could come as early as April 2.
Semiconductor and pharmaceutical tariffs would also come around the 25% level and could increase throughout 2025. No date for these tariffs has been announced or planned by Trump and the White House administration.
Trump has targeted China, Canada and Mexico with tariffs or threats of tariffs since taking office in January.
Benzinga recently asked if the tariffs could impact stock market indexes like the S&amp;P 500, which is tracked by the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>).
"How will Trump's tariffs affect the stock market?" Benzinga asked.
The results were:
<ul>
<li>Weigh down: 59%</li>
<li>Push higher: 23%</li>
<li>No real impact: 19%</li>
</ul>
The majority of respondents said Trump's tariffs will send the stock market lower. The remaining voters were split nearly even between the stock market going higher as the result of tariffs or the tariffs not having a real impact on stock market returns.
Read Also: <a href="https://www.benzinga.com/news/global/25/02/43442219/why-beer-tequila-avocados-cars-iphone-prices-could-rise-trumps-tariffs-on-canada-mexico-china-to-hurt-several-sectors">Why Beer, Tequila, Avocados, Cars, iPhone Prices Could Rise: Trump&#8217;s Tariffs On Canada, Mexico, China To Hurt Several Sectors</a>
Why It's Important: Trump recently said the White House will go country by country and adjust trade relations with "fair and reciprocal" tariffs.
This process, along with targeting certain specific industries, could see stocks hurt by the impact as costs are passed on to companies and consumers for the trade wars.
&#8220;I&#8217;ve decided, for purposes of fairness, that I will charge a reciprocal tariff, meaning whatever countries charge the United States of America,&#8221; Trump said, as&nbsp;<a href="https://www.nbcnews.com/business/economy/trump-reciprocal-tariffs-what-products-countries-how-much-rcna192075" target="_blank" rel="noreferrer noopener">reported&nbsp;</a>by NBC. &#8220;In almost all cases, they&#8217;re charging us vastly more than we charge them but those days are over.&#8221;
Benzinga<a href="https://www.benzinga.com/news/global/25/02/43712690/exclusive-will-trumps-chinese-tariffs-help-or-hurt-americas-economy-54-say-this"> recently polled readers</a> to see if they think the tariffs on China will be good or bad for the American economy.
&#8220;Will Trump&#8217;s tariffs on China help or hurt the U.S. economy?&#8221; Benzinga asked.
The results were:
<ul>
<li>Hurt businesses and consumers: 54%</li>
<li>Help the economy: 36%</li>
<li>No real impact: 10%</li>
</ul>
The winner of the poll was that tariffs on China will hurt businesses and consumers in America.
While Trump has called the tariff moves a way to fight the trade imbalances, other countries have threatened America with retaliatory measures like tariffs of their own or other measures. The Wall Street Journal said China was looking to target American companies with antitrust concerns. The list of companies China could target includes Nvidia, Apple, Broadcom and Alphabet.
China is now<a href="https://www.benzinga.com/news/global/25/02/43600852/china-sets-sights-on-us-tech-companies-as-trade-tensions-rise" target="_blank" rel="noreferrer noopener">&nbsp;turning its attention&nbsp;</a>to targeting American technology companies with trade relations escalating according to a new report.
The Wall Street Journal said China is looking at targeting American tech companies with antitrust concerns in the country. The list of companies China could target includes Nvidia, Apple, Broadcom and Alphabet. &nbsp;
A previous&nbsp;<a href="https://www.benzinga.com/etfs/broad-u-s-equity-etfs/25/01/43041374/exclusive-how-high-will-sp-500-go-under-donald-trump-in-2025-readers-are-optimistic-26-say-this" target="_blank" rel="noreferrer noopener">Benzinga reader survey</a>&nbsp;asked how high investors thought the SPY could go in 2025, Trump&#8217;s first year back in the White House.
In 2017, the SPDR S&amp;P 500 ETF Trust was up 21.7%. This was the first year with Trump in office and many sectors saw gains during the year.
When asked what they thought the return of the SPY would be in 2025, these were the results:
<ul>
<li>16%+: 26%</li>
<li>11% to 15%: 22%</li>
<li>Will Decline: 22%</li>
<li>6% to 10%: 19%</li>
<li>0% to 5%: 12%</li>
</ul>
The poll found that the largest percentage believed that the S&amp;P 500 Index would post gains of at least 16% in 2025. The 11% to 15% range came in second place at 22%.
It's also worth pointing out that the S&amp;P 500 decline in 2025 was tied for second in the poll at 22%. This could mean 2025 is a make-or-break year.
SPY Price Action: The SPDR S&amp;P 500 ETF Trust trades at $611.79 on Wednesday versus a 52-week range of $493.56 to $611.96, a new high hit earlier in Wednesday&#8217;s trading session. The ETF is up 23.2% in the past year. 
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/global/25/02/43795579/warren-buffett-unfazed-by-trumps-tariff-threats-oracle-of-omaha-bets-on-mexico-beer">Warren Buffett Unfazed By Trump&#8217;s Tariff Threats: Oracle Of Omaha Bets On Mexico, Beer</a></li>
</ul>
The study was conducted by Benzinga from Feb. 11, 2025 through Feb. 12, 2025. It included the responses of a diverse population of adults 18 or older. Opting into the survey was completely voluntary, with no incentives offered to potential respondents. The study reflects results from 119 adults.
Image: Shutterstock

Politics

Exclusives

EXCLUSIVE: Will Trump's Tariffs Hurt Or Help Stock Market? 59% Say This…

In the current session, the stock is trading at $16.96, after a 0.53% spike. Over the past month, Upwork Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPWK#NASDAQ">UPWK</a>) stock increased by 11.51%, and in the past year, by 36.45%. With performance like this, long-term shareholders are optimistic but others are more likely to look into the price-to-earnings ratio to see if the stock might be overvalued.

<img src="https://www.benzinga.com/files/images/story/2025/1739994318_0.png" alt="Past Year Chart" />

<h3>How Does Upwork P/E Compare to Other Companies?</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Upwork has a lower P/E than the aggregate P/E of 108.1 of the Professional Services industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1739994318_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

UPWK

Price Over Earnings Overview: Upwork

Rivian Automotive Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIVN#NASDAQ">RIVN</a>) will be reporting its fourth-quarter earnings on Thursday. Wall Street expects a loss of 65 cents per share and $1.40 billion in revenues as the company reports<a href="https://www.benzinga.com/calendars/earnings?tickers=RIVN" target="_blank" rel="noreferrer noopener"> after market hours</a>.
The stock is down 11.42% over the past year, up 6.23% YTD.
Let&#8217;s look at what the charts indicate for Rivian stock and how the stock currently maps against Wall Street estimates.
Read Also: <a href="https://www.benzinga.com//node/43615392">Rivian To Hike R1T, R1S Prices In Canada By Nearly 10% From Feb 25 Amid Exchange Rate Shift</a>
<h2 class="wp-block-heading">Rivian Stock Strongly Bullish Ahead Of Q4 Earnings</h2>
Rivian stock is displaying strong bullish momentum, with its share price currently trading above key moving averages. The stock is positioned above its five-day, 20-day and 50-day exponential moving averages, indicating sustained buying pressure. 
<figure class="wp-block-image size-full"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022025&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="629" height="489" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/19133658/Screenshot-2025-02-20-at-12.04.36-AM.png" alt="" class="wp-image-789671" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/19133658/Screenshot-2025-02-20-at-12.04.36-AM.png 629w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/19133658/Screenshot-2025-02-20-at-12.04.36-AM-300x233.png 300w" sizes="(max-width: 629px) 100vw, 629px" /></a></figure>
<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent022025&amp;t=be2bearmibe3na1">Chart created using Benzinga Pro</a>
At $14.11, Rivian stock is well above its eight-day simple moving average of $13.28, its 20-day simple moving average of $12.91 and its 50-day simple moving average of $13.56, all reinforcing a bullish trend. 
Additionally, the stock remains above its 200-day simple moving average of $12.63, confirming strength in the long-term uptrend.
Momentum indicators also support the bullish outlook. The Moving Average Convergence Divergence (MACD) indicator stands at 0.12, signaling positive momentum. Meanwhile, Rivian stock's Relative Strength Index (RSI) is at 58.51, suggesting the stock is nearing overbought levels but still has room for further gains. 
As long as Rivian stock holds above these key technical levels, the bullish trend remains intact.
<h2 class="wp-block-heading">Rivian Analysts See 2% Downside</h2>
Ratings &amp; Consensus Estimates:<a href="https://www.benzinga.com/quote/RIVN/analyst-ratings" target="_blank" rel="noreferrer noopener"> The consensus analyst rating</a> on Rivian stock stands at a Buy currently with a price target of $15.87. The latest analyst ratings from Barclays, UBS and Truist Securities give Rivian a $14 target.
RIVN Stock Price Action: Rivian stock was down 2.39% at $14.11 at the time of publication Wednesday.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com//node/43806303">Tesla-Rival Rivian&#8217;s $6.6 Billion Federal Loan Under Scrutiny As Trump Administration Reviews Funding</a></li>
</ul>
Photo: Shutterstock

Technicals

Previews

RIVN

Rivian's Technical Setup Signals Strength Ahead Of Q4 Earnings

Shares of nuclear components and fuel supplier BWX Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BWXT#NYSE">BWXT</a>) are<a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener"> trading higher </a>on Wednesday.
The company has been awarded contracts totaling approximately $2.1 billion from the U.S. <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/b43809100/bwxt-announces-2-1-billion-in-contracts-for-naval-nuclear-reactor-components" rel="noreferrer noopener">Naval Nuclear Propulsion Program</a>.
These agreements are centered on manufacturing reactor components for the Columbia and Virginia class submarines, along with Ford class aircraft carriers.
The work will be carried out at multiple BWX Technologies facilities in Lynchburg, Virginia, Barberton and Euclid, Ohio, and Mount Vernon, Indiana, over a seven-year period beginning in 2023.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/legal/25/02/43778605/tesla-files-fresh-lawsuit-against-matthews-after-court-defeat" rel="noreferrer noopener">Tesla Files Fresh Lawsuit Against Matthews After Court Defeat</a>
Alongside the reactor component contracts, BWX Technologies is also responsible for manufacturing nuclear fuel. This contract, valued at around $300 million, was awarded and announced in October 2023. The project is slated for completion by the end of this year.
&#8220;For more than 70 years, BWXT has proudly supported the U.S. Navy&#8217;s mission to defend freedom and uphold security across the globe,&#8221; said BWXT Nuclear Operations Group, Inc. president Gary D. Camper.
&#8220;These contracts represent not just our unmatched expertise in naval nuclear power but also our dedication to empowering the Navy with the tools needed to ensure the seas remain free and open.&#8221;
Price Action: BWXT shares are trading higher by 2.44% at $109.34 at the last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43791589/why-is-uber-stock-trading-higher-on-tuesday" target="_blank" rel="noreferrer noopener">Uber&#8217;s Ski Service Launches Across Europe: Details</a></li>
</ul>
Image via Shutterstock.

Contracts

General

BWXT

What's Going On With BWX Technologies Stock Today?

Celsius Holdings's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CELH#NYSE">CELH</a>) short percent of float has risen 18.37% since its last report. The company recently reported that it has 37.19 million shares sold short, which is 20.49% of all regular shares that are available for trading. Based on its trading volume, it would take traders 5.23 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?utm_source=insights&amp;adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?utm_source=insights&amp;adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Celsius Holdings Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739993426_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Celsius Holdings has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Celsius Holdings's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Celsius Holdings's peer group average for short interest as a percentage of float is 5.31%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?utm_source=insights&amp;adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

CELH

What Does the Market Think About Celsius Holdings?

Toll Brothers's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TOL#NYSE">TOL</a>) short percent of float has risen 29.53% since its last report. The company recently reported that it has 3.47 million shares sold short, which is 4.65% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.22 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?utm_source=insights&amp;adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?utm_source=insights&amp;adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>Toll Brothers Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739993421_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Toll Brothers has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Toll Brothers's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, Toll Brothers's peer group average for short interest as a percentage of float is 10.27%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?utm_source=insights&amp;adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Is The Market Feeling About Toll Brothers?

MetLife's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MET#NYSE">MET</a>) short percent of float has fallen 8.53% since its last report. The company recently reported that it has 6.80 million shares sold short, which is 1.18% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.89 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?utm_source=insights&amp;adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?utm_source=insights&amp;adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>MetLife Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739993415_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for MetLife has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing MetLife's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, MetLife's peer group average for short interest as a percentage of float is 2.36%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?utm_source=insights&amp;adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

How Do Investors Really Feel About MetLife?

<a href="https://www.benzinga.com/topic/george-soros">Billionaire investor George Soros</a> made some bold portfolio adjustments in the fourth quarter, signaling a shift toward growth while easing off defensive bets. 
Soros Fund Management's latest 13F filing shows fresh bets on Alphabet Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) and small-cap stocks, alongside a significant reduction in its SPDR S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) put position.
Meanwhile, the fund trimmed its stake in Alibaba Group Holding Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABAF#NYSE">BABAF</a>) and fully exited Oracle Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>), reflecting a shifting stance on Chinese tech.
<h2 class="wp-block-heading">Doubling Down On Alphabet, Small Caps</h2>
Alphabet emerged as one of Soros' biggest buys, with the fund increasing its stake by 2.55%. 
The firm also ramped up its exposure to the iShares Russell 2000 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IWM#NYSE">IWM</a>), a play on smaller, high-growth companies. 
This move suggests Soros is betting on a continued rebound in both mega-cap tech and smaller, more volatile stocks.
Read Also: <a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43816112/hedge-fund-shake-up-tiger-appaloosa-soros-outperform-buffett-icahn-ackman">Hedge Fund Shake-Up: Tiger, Appaloosa, Soros Outperform Buffett, Icahn, Ackman</a>
<h2 class="wp-block-heading">Cutting Market Hedges, Adding Fixed Income</h2>
Soros Fund slashed its SPY put position by nearly 15%, signaling reduced bearish sentiment on the broader market. &#8216;
The fund also trimmed holdings in The Financial Select Sector SPDR Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>) and iShares Core S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IVV#NYSE">IVV</a>), while increasing exposure to Ford Motor Co&#8216;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) debt and the iShares 20+ Year Treasury Bond ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TLT#NASDAQ">TLT</a>) calls — moves that hint at an evolving fixed-income strategy.
<h2 class="wp-block-heading">China Exposure Shrinks As BABA Gets Trimmed</h2>
Alibaba stock took a hit in the fourth quarter as Soros scaled back his position, joining other investors in reassessing Chinese tech. 
Meanwhile, Smurfit WestRock PLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SW#NYSE">SW</a>) remained the fund's top holding at 5.71% of the portfolio, with Alphabet and AstraZeneca PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZN#NASDAQ">AZN</a>) rounding out the top three.
Soros' latest moves suggest a more optimistic take on U.S. growth stocks while pulling back on market hedges and Chinese tech bets.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43811538/5-top-tech-stocks-hedge-funds-have-been-bullish-on-in-q4-hint-its-not-nvidia">5 Top Tech Stocks Hedge Funds Have Been Bullish On In Q4 (Hint: It&#8217;s Not Nvidia)</a></li>
</ul>
Image: Shutterstock

Long Ideas

Hedge Funds

BABA

ALIBABA GROUP HOLDING LTD by Alibaba Group Holding Limited

BABAF

GOOGL

ORCL

iShares Trust Barclays 20+ Year Treasury Bond Fund

George Soros Makes Fresh Bets On Alphabet, Small Caps: What About SPY Puts And Alibaba?

On Wednesday, Precision BioSciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DTIL#NASDAQ">DTIL</a>) revealed initial results from the first administration of PBGENE-HBV in cohort 1, the lowest dose level <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/b43808780/precision-biosciences-announces-initial-safety-and-antiviral-activity-of-pbgene-hbv-in-the-elimina" rel="noreferrer noopener">of the ELIMINATE-B trial</a>.
The ELIMINATE-B trial is designed to investigate PBGENE-HBV at multiple ascending dose levels with three dose administrations per dose level in chronic Hepatitis B patients who are HBeAg-negative.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/01/42924720/precision-biosciences-gene-editing-platform-has-differentiated-mechanism-and-is-potentially-competitive-analyst" rel="noreferrer noopener">Precision BioSciences&#8217; Gene Editing Platform Has Differentiated Mechanism, And Is Potentially Competitive: Analyst</a>
PBGENE-HBV, which comprises an ARCUS-encoding mRNA encapsulated in a lipid nanoparticle (LNP), was safe and well tolerated in all three cohort 1 participants after the first administration of a 0.2 mg/kg dose. The planned dosing schedule in ELIMINATE-B allows for two additional administrations at this dose level while simultaneously investigating the next higher dose level.
Across the three participants dosed, none experienced a Grade ≥2 treatment-related adverse event or serious adverse event.
In addition to safety, PBGENE-HBV demonstrated a substantial reduction in Hepatitis B surface antigen (HBsAg) in two of the three participants following the first administration at dose level 1.
With a well-tolerated safety profile and early antiviral activity established at pre-specified time points, Precision will complete subsequent administrations in all cohort 1 patients.
The ELIMINATE-B study is currently enrolling HBeAg-negative chronic Hepatitis B patients at sites in Moldova, Hong Kong, and New Zealand.
The company is on schedule to provide additional administrations at this dose level and subsequently plans to escalate to higher dose levels to define the optimal dose and number of dose administrations for safely eliminating covalently closed circular DNA (cccDNA)&nbsp;and inactivating integrated HBV DNA.
Precision plans to share detailed clinical data throughout 2025. HC Wainwright analyst Patrick Trucchio reiterates Precision BioSciences with a Buy and maintains a $60 price target.
Price Action: DTIL stock is up 9.22% at $5.63 at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/health-care/25/02/43817640/philips-stock-falls-as-china-weakness-drags-q4-earnings-2025-outlook" target="_blank" rel="noreferrer noopener">Philips Stock Falls As China Weakness Drags Q4 Earnings, 2025 Outlook</a></li>
</ul>

Biotech

Health Care

DTIL

Precision BioSciences Touts Encouraging Initial Safety And Antiviral Activity Of Hepatitis B Treatment Candidate

BlackRock, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>) shares are trading <a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener">relatively flat on Wednesday.</a>
The company has reportedly canceled meetings with companies amid U.S. Securities and Exchange Commission&#8217;s new investor activism rules, raising concerns over the future of environmental, social, and governance engagement, The Financial Times <a target="_blank" href="https://www.ft.com/content/533f9322-f098-4b82-823f-a7a8ef9350f1" rel="noreferrer noopener">reports</a>.
The SEC&#8217;s recent rule changes, which target the influence of ESG factors in investing, have forced BlackRock to pause its usual &#8220;stewardship&#8221; meetings while it assesses the new regulatory landscape, the report adds, citing people familiar with the discussions.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, BLK stock has gained over 22% in the past year. Investors can gain exposure to the stock via&nbsp;Fidelity Disruptive Finance ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FDFF#NASDAQ">FDFF</a>).
Also Read: <a target="_blank" href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43816112/hedge-fund-shake-up-tiger-appaloosa-soros-outperform-buffett-icahn-ackman" rel="noreferrer noopener">Hedge Fund Shake-Up: Tiger, Appaloosa, Soros Outperform Buffett, Icahn, Ackman</a>
The SEC&#8217;s updated guidelines impose more stringent requirements on fund managers who aim to influence corporate behavior, such as pressing for changes in executive compensation or promoting climate risk disclosures.
Previously, managers owning more than 5% of a company could file a relatively simple 13-G form, but now they may need to file a 13-D, triggering more complex disclosures and deadlines.
This regulatory shift complicates BlackRock&#8217;s ability to engage on key ESG topics and undermines efforts to address corporate governance issues like poison pill plans, the report further notes.
The rule changes have drawn criticism for curbing the power of fund managers to press companies on social and environmental issues, especially as conservative lawmakers intensify pressure on firms like BlackRock over their perceived influence on corporate America.
As BlackRock and other asset managers navigate these new requirements, the broader impact on ESG investing and corporate governance remains unclear.
Price Action: BLK shares are trading higher by 0.86% to $986.23 at last check Wednesday.
Read Also:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/02/43766008/berkshire-hathaways-13f-filing-suggests-a-buffett-style-bash-pizza-beer-and-fine-wine" target="_blank" rel="noreferrer noopener">Berkshire Hathaway&#8217;s 13F Filing Suggests a Buffett-Style Bash — Pizza, Beer and Fine Wine</a></li>
</ul>
Photo by rafapress on Shutterstock.

Media

FDFF

What's Going On With BlackRock Stock Today?

On Wednesday, Harmony Biosciences Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRMY#NASDAQ">HRMY</a>) received a Refusal to File (RTF) letter from the U.S. Food and Drug Administration (FDA) for pitolisant for excessive daytime sleepiness (EDS) in adult patients <a target="_blank" href="https://www.benzinga.com/pressreleases/25/02/b43810390/harmony-biosciences-provides-update-on-the-status-of-the-supplemental-new-drug-application-for-pit" rel="noreferrer noopener">with idiopathic hypersomnia (IH)</a>.
Harmony&#8217;s 2025 net revenue guidance of $820 million-$860 million remains unchanged.
&#8220;We are disappointed with this short-term setback, but our long-term strategy for pitolisant in IH remains firmly on track with our focus on Pitolisant HD,&#8221; said Jeffrey M. Dayno, President and Chief Executive Officer of Harmony Biosciences. &#8220;We are on track to initiate a Phase 3 registrational trial of Pitolisant HD in IH in Q4 2025, with a target PDUFA date in 2028.&#8221;
Also Read: <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/09/40802152/neurology-focused-harmony-biosciences-gains-confidence-with-wakix-sales-surge-strat" rel="noreferrer noopener">Neurology-Focused Harmony Biosciences Gains Confidence With Wakix Sales Surge, Strategic Pipeline Expansion, Bullish Analyst Says</a>
Although the primary outcome for excessive daytime sleepiness (EDS) between pitolisant and placebo did not reach statistical significance in the randomized withdrawal phase of the Phase 3 INTUNE Study, the data from the open-label phase showed that patients experienced improvements on the Epworth Sleepiness Scale that were five times greater than what is recognized as clinically meaningful.
Furthermore, most patients in the long-term extension study achieved normal levels of wakefulness and sustained this response beyond one year.
Pitolisant is marketed as Wakix&nbsp;in the U.S. for EDS or cataplexy in adult patients with narcolepsy and for EDS in pediatric patients 6 years of age and older with narcolepsy.&nbsp;It is not currently approved for IH.
In January, the company reported preliminary net product revenue for the fourth quarter of approximately $201 million, compared to $168.4 million a year ago and the <a target="_blank" href="https://www.benzinga.com/calendars/earnings" rel="noreferrer noopener">consensus of $198.6 million</a>.
The average number of patients on Wakix increased by approximately 300 sequentially to approximately 7,100 for the quarter <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/b42942961/harmony-biosciences-reports-strong-2024-revenues-provides-2025-revenue-guidance-and-highlights-key" rel="noreferrer noopener">ended December 31, 2024</a>.
Needham analyst Ami Fadia maintains Harmony Biosciences with a Buy and lowers the price <a target="_blank" href="https://www.benzinga.com/quote/HRMY/analyst-ratings" rel="noreferrer noopener">target from $52 to $50</a>.
Price Action: HRMY stock is down 6.50% at $36.55 at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/02/43815970/ai-meets-water-palantir-partners-with-saur-for-smarter-contract-management" target="_blank" rel="noreferrer noopener">Palantir Strikes AI Deal With SAUR For Contract Management: Details</a></li>
</ul>

HRMY

Harmony Biosciences Stock Falls On FDA Setback For Pitolisant In Sleeping Disorder

Blockstream CEO Adam Back believes Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) is entering a fresh bull market, citing strong inflows from ETFs <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43790066/institutions-can-earn-bitcoin-yield-with-lstbtc-while-retaining-custodian-security">and institutional investors.</a>
What Happened: "We're certainly in the early stages of a bull market," Back <a href="https://x.com/Cointelegraph/status/1892255600119001153">told</a> CNBC on Wednesday, emphasizing the growing demand for Bitcoin among financial institutions.
Back highlighted that Bitcoin ETFs are currently absorbing twice the daily mined supply, with firms like MicroStrategy further adding to the buying pressure. 
"Really, there's a lot of inflow," he said, adding that despite short-term profit-taking by midterm investors, structural demand remains robust.
Bitcoin is currently trading at $96,000, gaining 2% for the day, while Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) is up 3% at $2,705.
Other major cryptocurrencies are also rallying, with BNB (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/bnb/usd">BNB</a>) up 2.5%, Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>) up 3.5% to $170.5, and Litecoin (CRYPTO: LITE) surging 8%. 
Meme coins Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>) and Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) are trading flat.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/25/02/43816143/study-shows-reasons-why-bitcoin-ethereum-dogecoin-shiba-inu-plummet-from-their-all-time-highs">Study Shows Reasons Why Bitcoin, Ethereum, Dogecoin, Shiba Inu Plummet From Their All-Time Highs</a>
Why It Matters: Back noted that institutional adoption is accelerating, with ETF 13F filings revealing that 30% of Bitcoin ETF buyers are institutions.
He expects pension and mutual funds to increase their allocations in the coming cycle. "There's a lot of room for capital to come in," he said.
Additionally, Back suggested Bitcoin could soon compete with gold ETFs as capital reallocates from traditional safe-haven assets. 
He also pointed to sovereign treasuries as a potential catalyst, stating that if one major nation adds Bitcoin to reserves, "others will feel forced to follow suit."
With institutional capital and treasury investments increasing, the market could be poised for further gains, reinforcing Back's view that Bitcoin remains in the early innings of a sustained rally.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/25/02/43815939/binanceus-restores-usd-services-after-lengthy-regulatory-roadblock">Binance.US Restores USD Services After Lengthy Regulatory Roadblock</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BNB

$BTC

$DOGE

$SHIB

$SOL

Bitcoin 'Early In Bull Market,' Can Compete With Gold ETFs, Blockstream CEO Says

WIIM

Eason Technology shares are trading higher after the company announced it has acquired Hongkong Starlux Intelligent Technology.

Whales with a lot of money to spend have taken a noticeably bullish stance on Novo Nordisk.
Looking at options history for Novo Nordisk (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) we detected 12 trades.
If we consider the specifics of each trade, it is accurate to state that 58% of the investors opened trades with bullish expectations and 41% with bearish.
From the overall spotted trades, 2 are puts, for a total amount of $136,075 and 10, calls, for a total amount of $989,743.
<h3>Expected Price Movements</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $70.0 to $125.0 for Novo Nordisk during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Novo Nordisk's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Novo Nordisk's whale activity within a strike price range from $70.0 to $125.0 in the last 30 days. 
<h3>Novo Nordisk Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739992546_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NVO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$5.3</td>
<td>$5.0</td>
<td>$5.05</td>
<td>$110.00</td>
<td>$606.0K</td>
<td>1.9K</td>
<td>1.2K</td>
</tr>
<tr>
<td>NVO</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$18.0</td>
<td>$17.8</td>
<td>$18.0</td>
<td>$95.00</td>
<td>$106.2K</td>
<td>601</td>
<td>60</td>
</tr>
<tr>
<td>NVO</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$5.65</td>
<td>$5.55</td>
<td>$5.55</td>
<td>$85.00</td>
<td>$73.2K</td>
<td>2.1K</td>
<td>95</td>
</tr>
<tr>
<td>NVO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$18.0</td>
<td>$17.8</td>
<td>$17.8</td>
<td>$75.00</td>
<td>$53.4K</td>
<td>199</td>
<td>2</td>
</tr>
<tr>
<td>NVO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$14.95</td>
<td>$14.7</td>
<td>$14.85</td>
<td>$70.00</td>
<td>$46.0K</td>
<td>44</td>
<td>31</td>
</tr>
</tbody>
</table>

<h3>About Novo Nordisk</h3>
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting roughly 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Having examined the options trading patterns of Novo Nordisk, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Where Is Novo Nordisk Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 3,760,951, the NVO's price is up by 1.01%, now at $83.16. </li>
<li>RSI readings suggest the stock is currently may be approaching overbought.</li>
<li>Anticipated earnings release is in 77 days.</li>
</ul>
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Novo Nordisk options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Options

Spotlight on Novo Nordisk: Analyzing the Surge in Options Activity

Whales with a lot of money to spend have taken a noticeably bullish stance on Intuit.
Looking at options history for Intuit (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTU#NASDAQ">INTU</a>) we detected 13 trades.
If we consider the specifics of each trade, it is accurate to state that 53% of the investors opened trades with bullish expectations and 30% with bearish.
From the overall spotted trades, 8 are puts, for a total amount of $351,320 and 5, calls, for a total amount of $362,470.
<h3>Projected Price Targets</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $530.0 and $670.0 for Intuit, spanning the last three months.
<h3>Volume &amp; Open Interest Development</h3>
In terms of liquidity and interest, the mean open interest for Intuit options trades today is 185.6 with a total volume of 128.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Intuit's big money trades within a strike price range of $530.0 to $670.0 over the last 30 days.
<h3>Intuit Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739992541_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>INTU</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$19.8</td>
<td>$18.0</td>
<td>$18.0</td>
<td>$565.00</td>
<td>$173.0K</td>
<td align="right">147</td>
<td align="right">10</td>
</tr>
<tr>
<td>INTU</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$72.4</td>
<td>$64.4</td>
<td>$70.0</td>
<td>$600.00</td>
<td>$126.0K</td>
<td align="right">303</td>
<td align="right">0</td>
</tr>
<tr>
<td>INTU</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$104.0</td>
<td>$99.0</td>
<td>$99.0</td>
<td>$610.00</td>
<td>$99.0K</td>
<td align="right">20</td>
<td align="right">10</td>
</tr>
<tr>
<td>INTU</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$25.8</td>
<td>$24.9</td>
<td>$25.8</td>
<td>$580.00</td>
<td>$38.7K</td>
<td align="right">387</td>
<td align="right">48</td>
</tr>
<tr>
<td>INTU</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>03/21/25</td>
<td>$24.8</td>
<td>$24.5</td>
<td>$24.5</td>
<td>$580.00</td>
<td>$36.7K</td>
<td align="right">387</td>
<td align="right">0</td>
</tr>
</tbody>
</table>

<h3>About Intuit</h3>
Intuit is a provider of small-business accounting software (QuickBooks), personal tax solutions (TurboTax), and professional tax offerings (Lacerte). Founded in the mid-1980s, Intuit controls the majority of US market share for small-business accounting and do-it-yourself tax-filing software.
<h3>Where Is Intuit Standing Right Now?</h3>
<ul>
<li>With a volume of 914,340, the price of INTU is down -0.59% at $576.52. </li>
<li>RSI indicators hint that the underlying stock may be approaching oversold.</li>
<li>Next earnings are expected to be released in 6 days.</li>
</ul>
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>.
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Intuit with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

INTU

Check Out What Whales Are Doing With INTU

Whales with a lot of money to spend have taken a noticeably bullish stance on Roblox.
Looking at options history for Roblox (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RBLX#NYSE">RBLX</a>) we detected 14 trades.
If we consider the specifics of each trade, it is accurate to state that 50% of the investors opened trades with bullish expectations and 42% with bearish.
From the overall spotted trades, 6 are puts, for a total amount of $221,365 and 8, calls, for a total amount of $315,360.
<h3>Projected Price Targets</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $30.0 to $79.0 for Roblox during the past quarter. 
<h3>Insights into Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Roblox stands at 1006.23, with a total volume reaching 1,126.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Roblox, situated within the strike price corridor from $30.0 to $79.0, throughout the last 30 days.
<h3>Roblox Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1739992536_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>RBLX</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/18/25</td>
<td>$15.6</td>
<td>$15.15</td>
<td>$15.6</td>
<td>$52.50</td>
<td>$68.6K</td>
<td>106</td>
<td align="right">1</td>
</tr>
<tr>
<td>RBLX</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$4.35</td>
<td>$4.3</td>
<td>$4.3</td>
<td>$65.00</td>
<td>$45.5K</td>
<td>1.7K</td>
<td align="right">110</td>
</tr>
<tr>
<td>RBLX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>09/19/25</td>
<td>$22.55</td>
<td>$21.85</td>
<td>$22.32</td>
<td>$45.00</td>
<td>$44.6K</td>
<td>144</td>
<td align="right">20</td>
</tr>
<tr>
<td>RBLX</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$6.9</td>
<td>$6.8</td>
<td>$6.8</td>
<td>$72.50</td>
<td>$43.5K</td>
<td>456</td>
<td align="right">64</td>
</tr>
<tr>
<td>RBLX</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>03/07/25</td>
<td>$14.5</td>
<td>$14.3</td>
<td>$14.3</td>
<td>$79.00</td>
<td>$42.9K</td>
<td>1</td>
<td align="right">30</td>
</tr>
</tbody>
</table>

<h3>About Roblox</h3>
Roblox operates an online video game platform with 80 million daily active users that lets young gamers create, develop, and monetize games (or "experiences") for other players. The firm offers its developers a hybrid of a game engine, publishing platform, online hosting and services, marketplace with payment processing, and social network. The platform is a closed garden that Roblox controls, earning $3.5 billion in bookings in 2023 through in-game purchases and advertising while benefiting from outsourced game development. Unlike traditional video game publishers, Roblox is more focused on the creation of new tools and monetization techniques for its developers than creating new games or franchises.
After a thorough review of the options trading surrounding Roblox, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Where Is Roblox Standing Right Now?</h3>
<ul>
<li>With a trading volume of 2,865,542, the price of RBLX is down by -3.28%, reaching $63.93.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 78 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Roblox</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $69.2.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Citigroup persists with their Buy rating on Roblox, maintaining a target price of $82. 
&#x2A; Reflecting concerns, an analyst from Piper Sandler lowers its rating to Overweight with a new price target of $72. 
&#x2A; Maintaining their stance, an analyst from Roth MKM continues to hold a Neutral rating for Roblox, targeting a price of $70. 
&#x2A; An analyst from Macquarie has decided to maintain their Outperform rating on Roblox, which currently sits at a price target of $76. 
&#x2A; Maintaining their stance, an analyst from Barclays continues to hold a Equal-Weight rating for Roblox, targeting a price of $46. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Roblox, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

RBLX

Roblox's Options: A Look at What the Big Money is Thinking

Shares of Alibaba Group Holding Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BABA#NYSE">BABA</a>) are off slightly ahead of tomorrow's report. The company will release its earnings tomorrow and is scheduled to have a conference call at 7:30 AM EST to discuss the results.
Even if the earnings are good, there is a chance that the stock heads lower. This is why it is our <a href="https://www.benzinga.com/topic/stock-of-the-day">Stock of the Day</a>.
BABA has rallied by about 60% in just a few weeks. Analysts attribute this move to <a href="https://www.benzinga.com/general/market-summary/25/02/43806017/alibabas-q4-shakeup-many-asian-funds-exit-while-us-based-funds-like-ubs-oconnor-marathon-assetmark-cantor-fitzgerald-double-down">optimism around AI advancement.</a>
This could set the stage for what traders call a ‘crowded trade'. This would be bearish for the stock.
It means that because investors think the earnings will be good, the vast majority purchase shares ahead of the release. This makes the market effectively run out of buyers.
Stocks don't move higher unless traders and investors who wish to buy push the price up. A market with no buyers can't go up.
Read Also: <a href="https://www.benzinga.com/trading-ideas/long-ideas/25/02/43816112/hedge-fund-shake-up-tiger-appaloosa-soros-outperform-buffett-icahn-ackman">Hedge Fund Shake-Up: Tiger, Appaloosa, Soros Outperform Buffett, Icahn, Ackman</a>
If the earnings are good and the stock doesn't rally, some will become concerned and may decide to sell.&nbsp; But they will have a hard time finding buyers for their shares. They may need to push the price lower.
Others will see this and may decide to do the same. It could result in a snowball effect that results in a selloff even if the numbers beat expectations.
Technically, as you can see on the chart below, Alibaba is also extremely overbought.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="545" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/19141022/119-1024x545.png" alt="" class="wp-image-789703" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/19141022/119-1024x545.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/19141022/119-300x160.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/19141022/119-768x409.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/02/19141022/119.png 1518w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
This means the stock is trading above what would be its typical or normal range. Some technical traders will be anticipating a reversion to the mean or move lower. They may enter the market as sellers and this could put downward pressure on the stock.
The shares are also testing resistance around $124.00. The last three times they hit this level a selloff followed.
Resistance is a price level where there is a large amount of sell interest. Stocks can sell off of resistance if some of the people who created the resistance become willing to accept lower prices and start to undercut each other.
Excessive optimism about the earnings release, being overbought, and being at resistance means BABA may be about to head lower. Even if the earnings are good.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/general/travel/25/02/43814828/life-threatening-cold-air-snow-brings-travel-delays-higher-heating-costs">&#8216;Life-Threatening&#8217; Cold Air, Snow Brings Travel Delays, Higher Heating Costs</a></li>
</ul>
Image: Shutterstock

Stock Of The Day: Will A 'Crowded Trade' Force Alibaba Lower?

APTO

Aptose Biosciences shares are trading lower after the company announced a 1-for-30 reverse stock split.

WOOF

Petco Health and Wellness shares are trading lower. The company announced leadership changes at the company including the CFO.

Press Releases

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oklo Inc. - OKLO

Carbon Fiber Market Projected to Grow Significantly as Increasing Demand for Growing Number of Industries Rises

Oklo and RPower Join Forces to Accelerate Power Availability for Data Centers

Lightbridge and Oklo Sign MOU to Explore Co-Location of Commercial Fuel Fabrication Facilities and Collaboration on Advanced Fuel Recycling

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Oklo Inc. - OKLO

Oklo Announces Board Transition Following Chris Wright's Confirmation as Secretary of Energy

KULR

NVDA

American Electric Power Company, Inc. - Common Stock

American Electric Power

Constellation Energy Corporation - Common Stock

Constellation Energy

Comp En De Mn Cemig ADS American Depositary Shares

Cia Energetica DE Minas

Comp En De Mn Cemig ADS American Depositary Receipts

Duke Energy Corporation (Holding Company) Common Stock

Duke Energy

Centrais Electricas Brasileiras S A American Depositary Shares (Each representing one Common Share)

Centrais Eletricas

Centrais Electricas Brasileiras S.A. Sponsored ADS representing Pfd Shares

Edison Intl

Companhia Paranaense de Energia (COPEL) American Depositary Shares (each representing one Unit consisting one Common Share and four non-voting Class B Preferred Shares)

Cia Paranaense De Energia

Eversource Energy

Entergy

Evergy

Exelon

FirstEnergy

Idacorp

Korea Electric Power Corporation Common Stock

Korea Electric Power

Alliant Energy Corporation - Common Stock

Alliant Energy

NextEra Energy

NRG Energy

OGE Energy

PG&E

Pinnacle West Capital Corporation Common Stock

Comments

Oklo

Unusual Options Activity for

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga